UK Atopic Dermatitis Market Analysis


  • Type: Common Disease Area
  • Published : February 2022
  • Region: Europe
  • Country: UK
  • Report ID : 5062

  • Format: PPT, PDF

UK Atopic Dermatitis Market: Segmented by Treatment Type, Route of Administration, and Distribution Channel – Growth, Market Size, Future Prospects & Competitive Analysis, 2021–2028

SKU: 5062 Categories: ,

Report Description of the UK Atopic Dermatitis Treatment Market

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Research Objective:

  • To analyze and forecast the market size of UK Atopic Dermatitis Drugs market
  • To classify and forecast UK Atopic Dermatitis Market market based on application, drugs, project type, and application.
  • To identify drivers and challenges for UK Atopic Dermatitis market
  • To examine competitive developments such as mergers and acquisitions, agreements, collaborations and partnerships, etc., in UK Atopic Dermatitis market
  • To conduct pricing analysis for UK Atopic Dermatitis Drugs market
  • To identify and analyze the profile of leading players operating in UK Atopic Dermatitis market

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for Atopic Dermatitis drug market
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the Atopic Dermatitis market
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy-based consulting analysis

UK Atopic Dermatitis Market Executive Summary

The United Kingdom (UK) has a high prevalence of UK Atopic Dermatitis, affecting 11-20% of children and 5-10% of adults. Approximately 2% of all cases of childhood AD in the UK are severe. Despite this, most AD treatments are performed at home, with little contact with healthcare providers or services. Here, we discuss the course of AD, treatment practices, and unmet need in the UK. In next few years, the market of UK Atopic Dermatitis in UK expected to grow enormously with growing population.

Market Size and Key Findings

The UK Atopic Dermatitis treatment market size is at around USD xx billion in 2020 and is projected to reach USD xx billion in 2028, exhibiting a CAGR of xx% during the forecast period.

Atopic dermatitis is most common in infants especially in the first year after birth. According to the British Association of Dermatologists, one in every 5 children in the United Kingdom is affected by eczema at some stage. According to the estimates of the National Institute for Health and Care Excellence, atopic dermatitis affects 1 in every 12 adults in the United Kingdom. This in turn is propelling the growth of the market during the forecast period.

Market Dynamics

Market Growth Drivers Analysis

The market drivers include rising a growing patient population, numerous new products launches, climate change and also massive advancements in atopic dermatitis treatment. This factors are estimated to driven the atopic dermatitis market in UK.

Market Restraints

The critical restrictions on market expansion are stringent regulations and generic competition. In addition, the lack of competent individuals in hospitals and clinics and changes in economic strategy have a detrimental impact on the atopic dermatitis treatment market growth rate. Further, the market growth is slowed by the high cost of treatment procedures due to sophisticated features.

COVID-19 impact on “UK Atopic Dermatitis Treatment Market” 

As the result of COVID-19 there is lockdown and some restrictions throughout the borders. There is great economical unbalance throughout the world. Many segments have to face economic crises. But many companies of pharmaceutical sector still continue the manufacturing of products used for the treatment of atopic dermatitis. They fulfill the demand of patients and physicians of atopic dermatitis products. There is also increase in the demand of these products and also the price of these products gets increased. This is also beneficial for the leading players in atopic dermatitis market and thus many companies in derma sector gain extra profit in pandemic of COVID-19

Competitive Landscape

Key Players

Prominent Companies leading the Europe Atopic Dermatitis Treatment Market Profiled in the Report are Astellas Pharma Inc., Valeant Pharmaceuticals International, Inc., and Sanofi S.A. Other players in the market include Anacor Pharmaceuticals, Inc. Meda Pharmaceuticals, Regeneron Pharmaceuticals Inc., and Novartis International AG, Pfizer Inc.

Products in Pipeline

Phosphodiesterase is one of the targets. Crisaborole cream (brand name Eucrisa), a phosphodiesterase-4 inhibitor, was recently launched in North America and has been shown to have a very significant impact on itching. It should soon be available in the UK. It’s not going to change the world but it will lead to more research into phosphodiesterase inhibitors. Other drugs in this group have reached phase 2 and 3 levels in trials. It’s likely that these will be effective non-steroid treatments – particularly for itching – and will probably be as effective as topical calcineurin inhibitors (tacrolimus and pimecrolimus).

Notable Recent Deals

Pfizer Inc. Announced the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted Great Britain marketing authorization for CIBINQO® (abrocitinib), an oral, once-daily, Janus kinase 1 (JAK1) inhibitor, for the treatment of moderate to severe atopic dermatitis (AD) in adults and adolescents aged 12 years and over, who are candidates for systemic therapy. Abrocitinib is licensed in Great Britain in recommended doses of 100mg and 200mg. This is the first marketing authorization worldwide for this treatment.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario of UK Atopic Dermatitis Treatment

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and the European Commission (EC) have both approved Adtralza (tralokinumab) for the treatment of moderate-to-severe atopic dermatitis in adult patients who are candidates for systemic therapy. The approvals make tralokinumab the first and only approved biologic that specifically targets the interleukin 13 (IL-13) cytokine, a key driver of atopic dermatitis signs and symptoms.

1. Report Description of the UK Atopic Dermatitis Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. UK Atopic Dermatitis Market Executive Summary
2.1 UK Atopic Dermatitis Market – Industry Snapshot & key buying criteria, 2021-2028
2.2 Market Size, Growth Prospects and Key findings
3. Market Dynamics of UK Atopic Dermatitis Treatment Market
3.1 Market Growth Drivers Analysis
3.1.1 Rising a Growing Patient Population
3.1.2 Generic Competition
3.1.3 Numerous New Products Launches
3.1.4 Climate Change
3.1.5 Massive Advancements in Atopic Dermatitis Treatment
3.2 Market Restraints Analysis
3.2.1 Stringent Regulation and Generic Competition
3.2.2 Lack of Competent Individuals in hospitals/Clinics
3.2.3 Changes in Economic Strategy
3.2.4 High Cost of Treatment Procedure
3.3 Covid-19 Market Impact Analysis
3.3.1 Negative impact on outcomes
4. Fungal infection treatment Market Segmentation
4.1 By Treatment Analysis
4.1.1 Drug Treatment
4.1.2 Radiation Treatment
4.2 By Route of Administration Analysis:
4.2.1 Oral
4.2.2 Topical
4.3 By Distribution Channel Analysis:
4.3.1 Hospitals and Pharmacies
4.3.2 Retail Pharmacies and Drug stores
4.3.3 Online Pharmacies
5. Atopic Dermatitis Major Products Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Products in Pipeline
6.2 R&D Initiatives in UK Atopic Dermatitis Treatment Market
6.3 Notable recent deals in UK Atopic Dermatitis Treatment Market
6.3.1 Joint Ventures
6.3.2 Partnerships
6.3.3 Mergers & Acquisitions
6.3.4 Strategic divestments
7. Key Company Profiles
7.1 Astellas Pharma Inc.
Product & Services, Strategies & Financials
7.2 Valeant Pharmaceuticals Internationa, Inc.
Product & Services, Strategies & Financials
7.3 Sanofi S.ASanofi-Aventis Company Overview
Product & Services, Strategies & Financials
7.4 Anacor Pharmaceuticals, Inc. Company Overview
Product & Services, Strategies & Financials
7.5 Meda Pharmaceuticals Company Overview
Product & Services, Strategies & Financials
7.6 Regeneron Pharmaceuticals Inc. Overview
Product & Services, Strategies & Financials
7.7 Novartis International AG Company Overview
Product & Services, Strategies & Financials
7.8 Pfizer Inc. Company Overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Pricing and Reimbursement scenario of UK Atopic Dermatitis Treatment
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development of UK Atopic Dermatitis Treatment market
9.2 Future Opportunities
10. Strategic Recommendations

Atopic Dermatitis Market Segmentation

By Treatment Type:

Based on the drug type, the market is segmented into drug treatment and radiation treatment.

  • Drug Treatment
  • Radiation Treatment

By Route of Administration:

In terms of route of administration, the market is segmented into oral and topical.

  • Oral
  • Topical

By Distribution Channel:

Based distribution channel, results regular hospital visits obtaining advanced for the pharmacies & also anticipated emerge as the fastest-growing segment the market. the rise the drug supply medical professionals, healthcare centers, and others.

  • Hospitals and clinics
  • Retail Pharmacies and Drug stores
  • Online Pharmacies

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements